How Ozone Therapy Can Improve Cardiovascular Conditions
Ozone therapy represents a powerful, underutilised modality for addressing cardiovascular conditions through its multifaceted mechanisms of enhancing oxygenation, reducing inflammation, and improving circulation. By inducing controlled oxidative stress, ozone stimulates the body’s endogenous antioxidant systems, optimising cellular respiration and mitochondrial function, both critical to cardiovascular health. The process involves ozonated saline or autohemotherapy, where blood is withdrawn, oxygenated with ozone, and reinfused, effectively reducing viscosity and restoring microcirculation.
A primary cardiovascular benefit of ozone lies in its ability to upregulate oxygen utilisation. Chronic hypoxia (low oxygen) is a root driver of cardiovascular dysfunction, as oxygen deprivation forces cells into anaerobic metabolism, accelerating oxidative damage and plaque formation
Ozone counteracts this by increasing ATP production, 38 molecules per glucose molecule in oxygen-rich environments versus just 2 under hypoxia, directly enhancing myocardial efficiency
Ozone oxidises arterial plaque components like damaged LDL cholesterol, promotes inflammation reduction and ozone therapy may mitigate arterial stiffness and improve vascular elasticity
For patients with hypertension or ischemic heart disease, ozone improves nitric oxide (NO) synthesis, a vasodilator critical for blood pressure regulation. Nitric oxide’s half-life is brief (3 seconds), but ozone therapy enhances its bioavailability by stabilising endothelial function and reducing oxidative stress. Additionally, ozone’s hypo-coagulant effects decrease platelet aggregation, lowering thrombosis risk without the bleeding complications associated with pharmaceuticals like warfarin.
In summary, ozone therapy addresses cardiovascular disease at its roots: hypoxia, inflammation, and oxidative stress. By leveraging oxygen’s healing potential, it bypasses the limitations of conventional toxic interventions, offering a path to true vascular resilience.
REFERENCES:
Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017 Oct 17;7(3):212-219. doi: 10.4103/2045-9912.215752. PMID: 29152215; PMCID: PMC5674660.
Pandolfi S, Valdenassi L, Franzini M, Simonetti V, Chirumbolo S. Insights into the use of oxygen-ozone therapy in ischemic cardiopathy and cardiovascular disease: a role for mitochondria? Med Gas Res. 2024 Dec 1;14(4):164-166. doi: 10.4103/mgr.MEDGASRES-D-23-00007. Epub 2024 Mar 28. PMID: 40434379; PMCID: PMC11257178.